[Therapeutic algorithm for lipoprotein apheresis and PCSK9 inhibition for severe hypercholesterolemia or isolated lipoprotein(a) hyperlipoproteinemia]

Internist (Berl). 2016 May;57(5):511-6. doi: 10.1007/s00108-016-0043-9.
[Article in German]
No abstract available

Keywords: Apheresis, lipoproteins; Cardiovascular diseases; Cholesterol, LDL; Guideline; PCSK9-Inhibitors.

MeSH terms

  • Algorithms*
  • Blood Component Removal / standards*
  • Evidence-Based Medicine
  • Germany
  • Humans
  • Hypercholesterolemia / blood
  • Hypercholesterolemia / diagnosis
  • Hypercholesterolemia / therapy*
  • Hyperlipoproteinemias / blood
  • Hyperlipoproteinemias / diagnosis
  • Hyperlipoproteinemias / therapy*
  • Lipoprotein(a) / blood*
  • Lipoprotein(a) / isolation & purification
  • Lipoproteins
  • PCSK9 Inhibitors*
  • Practice Guidelines as Topic*
  • Treatment Outcome

Substances

  • Lipoprotein(a)
  • Lipoproteins
  • PCSK9 Inhibitors
  • PCSK9 protein, human